Genomic meta-analysis of growth factor and integrin pathways in chronic kidney transplant injury

BMC Genomics

Table 4 Clinical characteristics for the 33 samples that were analyzed with microarrays in our laboratory

	Banff0	CAN	Significance*
Subject Numbers	9	24
Recipient Age ± SD ^‡	49.7 ± 12.9	45.7 ± 13.1	NS^{^}
% Female Recipients	66.7	45.8	NS
% Recipient African American	0	8.33	NS
% Pre-tx Type II Diabetes	25	17.4	NS
% PRA > 20	0	9.5	NS
HLA Mismatch ± SD	2.3 ± 1.3	2.6 ± 3.2	NS
% Deceased Donor	66.7	69.6	NS
Donor Age ± SD	31.4 ± 13.6	41.6 ± 14.7	NS
% Female Donors	33.3	41.6	NS
% Donor African American	0	6.7	NS
% Induction	66.7	87.5	NS
Serum Creatinine ± SD	3.07 ± 1.2	1.78 ± 1.1	0.01
Time to Biopsy (Days) ± SD	691 ± 550	2009 ± 1367	0.0004
% Calcineurin Inhibitors	87.5	75	NS
% Mycophenolic Acid Derivatives	55.6	70.8	NS
% Oral Steroids	44.5	100	0.0005
C4d Positive Staining (%)	0	13	NS

* Significance for all comparisons were determined with paired Students t-test for pair-wise comparisons of data with Standard Deviations and for dichotomous data comparisons by Chi-Square.
^‡ SD = standard deviation from the mean.
^ NS = not significant (p ≥ 0.05).

ISSN: 1471-2164